Salem Investment Counselors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.4K Sell
398
-226
-36% -$19.8K ﹤0.01% 683
2026
Q1
$56.5K Buy
+624
New +$57.3K ﹤0.01% 570
2025
Q4
Sell
-623
Closed -$61.6K 1177
2025
Q3
$61.6K Sell
623
-7
-1% -$694 ﹤0.01% 558
2025
Q2
$57.6K Buy
630
+7
+1% +$677 ﹤0.01% 556
2025
Q1
$70.7K Hold
623
﹤0.01% 513
2024
Q4
$66K Sell
623
-20
-3% -$2.15K ﹤0.01% 526
2024
Q3
$69.6K Hold
643
﹤0.01% 514
2024
Q2
$69.9K Hold
643
﹤0.01% 502
2024
Q1
$85K Buy
643
+13
+2% +$1.62K ﹤0.01% 473
2023
Q4
$76.8K Sell
630
-65
-9% -$7.25K ﹤0.01% 480
2023
Q3
$78.1K Sell
695
-10
-1% -$1.27K ﹤0.01% 457
2023
Q2
$103K Hold
705
﹤0.01% 412
2023
Q1
$91.2K Buy
705
+41
+6% +$5.15K ﹤0.01% 433
2022
Q4
$84.9K Hold
664
﹤0.01% 437
2022
Q3
$70K Buy
664
+20
+3% +$2.19K ﹤0.01% 438
2022
Q2
$68K Buy
644
+10
+2% +$1.19K ﹤0.01% 457
2022
Q1
$81K Sell
634
-19
-3% -$2.29K ﹤0.01% 443
2021
Q4
$81K Hold
653
﹤0.01% 485
2021
Q3
$93K Sell
653
-88
-12% -$12.9K 0.01% 422
2021
Q2
$116K Hold
741
0.01% 387
2021
Q1
$115K Hold
741
0.01% 353
2020
Q4
$111K Hold
741
0.01% 337
2020
Q3
$98K Buy
741
+88
+13% +$11.5K 0.01% 307
2020
Q2
$76K Hold
653
0.01% 335
2020
Q1
$64K Buy
653
+206
+46% +$27K 0.01% 319
2019
Q4
$65K Buy
447
+1
+0.2% +$138 0.01% 350
2019
Q3
$60K Hold
446
0.01% 350
2019
Q2
$51K Sell
446
-103
-19% -$12.1K ﹤0.01% 370
2019
Q1
$70K Buy
+549
New +$62.4K 0.01% 266
2018
Q4
Sell
-549
Closed -$70K 396
2018
Q3
$70K Sell
549
-45
-8% -$5.35K 0.01% 266
2018
Q2
$64K Hold
594
0.01% 268
2018
Q1
$62K Hold
594
0.01% 270
2017
Q4
$70K Hold
594
0.01% 279
2017
Q3
$68K Buy
594
+92
+18% +$10.6K 0.01% 278
2017
Q2
$63K Sell
502
-286
-36% -$33.9K 0.01% 291
2017
Q1
$93K Hold
788
0.01% 311
2016
Q4
$79K Buy
+788
New +$84.5K 0.01% 316

Other funds holding ZBH

Salem Investment Counselors's ZBH Position: Q2 2026 in Review

Salem Investment Counselors reduced its Zimmer Biomet (ZBH) stake by 36% in Q2 2026, selling an estimated $19.8K and leaving 398 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #683.

Salem Investment Counselors first reported a position in ZBH in Q4 2016 and has held it in 37 quarters since. The position peaked at $116K in Q2 2021. 348 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Salem Investment Counselors held 398 shares of Zimmer Biomet worth $34.4K as of Q2 2026.
  • Salem Investment Counselors sold 226 Zimmer Biomet shares in Q2 2026, an estimated $19.8K.
  • Zimmer Biomet made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #683 holding.
  • Salem Investment Counselors first reported a position in Zimmer Biomet in Q4 2016 and has held it in 37 quarters since.
  • Salem Investment Counselors's Zimmer Biomet position peaked at $116K in Q2 2021.
  • 348 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.